Billerud launches SteriKraft® DirectSeal for sterile barrier packaging applications
As healthcare packaging requirements continue to evolve, medical device manufacturers face increasing demands for packaging that combines patient safety, manufacturing efficiency, and sustainability. To help meet these needs, Billerud is launching SteriKraft® DirectSeal, a new medical paper developed for sterile barrier packaging applications.
SteriKraft® DirectSeal is a surface-treated medical paper designed primarily for Thermo Form Fill Seal (TFFS) and pouch applications. Developed using advanced film-press technology, it is intended for sterile barrier packaging applications where package integrity, cleanliness and process reliability are critical.
"SteriKraft® DirectSeal represents an important step in our commitment to advancing medical packaging solutions. Leveraging advanced surface treatment technology, we have developed a medical paper that delivers enhanced seal and peel performance for direct-seal applications. Developed and produced at our integrated mill in Skärblacka, Sweden, it sets the foundation for a portfolio of high-performance medical papers designed to elevate packaging reliability, efficiency, and patient safety", says Florian Schäffeler, Senior Segment Manager Medical at Billerud.
The new paper is produced from pure Nordic fresh fibers under strict cleanliness controls, including extensive pulp cleaning, continuous web inspection, and regular bioburden monitoring. These measures help reduce contamination risk and support the stringent quality requirements associated with medical packaging applications.
Alongside performance and cleanliness, sustainability is becoming an increasingly key factor in healthcare packaging decisions. SteriKraft® DirectSeal is manufactured using renewable fiber from responsibly managed Nordic forests and benefits from Billerud’s integrated production system, helping reduce its carbon footprint without compromising performance.
The launch of SteriKraft® DirectSeal further strengthens Billerud’s healthcare packaging offering, which includes packaging materials developed for sterile medical products, medical applications, and pharmaceutical packaging.
SteriKraft® DirectSeal will be commercially available from 16 November 2026.
Facts: SteriKraft® DirectSeal
- Medical paper developed for sterile barrier packaging.
- Designed primarily for Thermo Form Fill Seal (TFFS) and pouch applications.
- Surface-treated using advanced film-press technology.
- Developed for enhanced seal and peel performance and compatibility with a broader range of medical films.
- Produced from pure Nordic fresh fibers under strict cleanliness controls.